Winston Posvar, OD, MS, FAAO

Articles by Winston Posvar, OD, MS, FAAO

Image credit: ©Nikolai Sorokin – stock.adobe.com

Using virtual reality mobility testing as a standardized clinical end point in inherited retinal disorders

ByGeorge Magrath, MD,Winston Posvar, OD, MS, FAAO,Andrew Pucker, OD, MS, PhD, FAAO

September 16th 2023

The use of VR mazes hold an intrinsic advantage compared with physical mazes in the ability to control conditions and test various patterns with reliability, participant safety, and repeatability.

Latest Updated Articles

Using virtual reality mobility testing as a standardized clinical end point in inherited retinal disorders
September 16th 2023

Winston Posvar, OD, MS, FAAO

Articles by Winston Posvar, OD, MS, FAAO

Using virtual reality mobility testing as a standardized clinical end point in inherited retinal disorders

Latest Updated Articles

Trending on Modern Retina

Merck launches phase 2b/3 MALBEC trial of MK-8748 in wet AMD

FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa

FDA approves extended dosing intervals up to 20 weeks for EYLEA HD in wAMD and DME

OLN324 shows comparable vision gains, potential durability advantage vs faricimab in phase 1b wAMD, DME study